For companies in the instrument industry, protecting patents is a crucial aspect of business. As was the case in last year’s article (see IBO 11/30/06), Bio-Rad, Applied Biosystems and Invitrogen continue to be among the most legally aggressive companies. First, to begin on a positive note, Bio-Rad’s suit against 4titude and Phenix Research Products was […]
On September 18, on the heels of a market correction, the Federal Reserve cut the Fed funds rate by a surprising half-point to 4.75%, sending the Dow, S&P 500 and NASDAQ up 2.5%, 2.9% and 2.7%, respectively. Signs of a slowing economy incited by the declining housing market apparently swayed the Fed to take drastic […]
Kingdom: Preliminary results from a survey by the Sensors and Instrumentation Knowledge Transfer Network (SIKTN) show that 57% of UK sensor and scientific instrument companies plan to boost research spending in the next year. On average, sensor and instrument companies in the UK intend to increase research spending by 10%. In addition, 75% of the […]
London, UK 9/19/07; 9/26/07—Smiths has announced that it will not proceed with its planned joint venture for detection technologies with GE Homeland Protection (see IBO 1/15/07). The announcement stated that the companies “were unable to agree on a strategic vision for the combined business.” Smiths would have owned 64% of the new company with GE […]
BTX Harvard Apparatus introduced the MicroPoration platform, consisting of a pulse generator, safety chamber and MicroPorator pipette, for nonviral transfection. Nova Biomedical launched the module BioProfile FLEX for cell culture analysis of 16 attributes. CellASIC launched the ONIX system for live cell imaging of yeast samples, featuring a microfluidic plate and flow control panel. Applied […]
Tokyo, Japan 9/25/07—Japan’s Nikkei News reports that Toshiba, Canon, Toray Industries, Yokogawa Electric and seven other Japanese firms, supported by the Kazusa DNA Research Institute, will form a consortium to develop microarrays for applications in diagnostic medicine, food and environmental analysis. According to Nikkei, the Japanese microarray market will total ¥100 billion ($869.2 million) by […]
A study by the Tufts Center for the Study of Drug Development (CSDD) has found that the number of cancer drugs in clinical development has more than doubled between 1990 and 2006. However, only 8% of these drug candidates received marketing approval during the studied period. When broken down by compound type, market approval percentages […]
BTX Harvard Apparatus introduced the MicroPoration platform, consisting of a pulse generator, safety chamber and MicroPorator pipette, for nonviral transfection. Nova Biomedical launched the module BioProfile FLEX for cell culture analysis of 16 attributes. CellASIC launched the ONIX system for live cell imaging of yeast samples, featuring a microfluidic plate and flow control panel. Applied […]
Due to the impending landfall of Hurricane Humberto in the United States, oil refineries in the affected region went off-line, sending oil prices over $80 per barrel for the first time in history. Although the price has since fallen, this and related incidents will no doubt continue to generate interest in both traditional and alternative […]
In July, Thermo Fisher Scientific announced the production of its 500th iCAP 6000 ICP emission spectrometer at its facility in Cambridge, UK. The product was shipped to Boeing.
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
